Nath Bio-Genes (India) Ltd

Nath Bio-Genes Q2 2025 Results: Revenue Surges, Profit Trends Mixed 📊

- Standalone revenue: ₹39,770.70 lakhs (Q2 2025) vs ₹26,017.18 lakhs (Q2 2024) – 53% YoY growth

- Standalone net profit: ₹420.09 lakhs (Q2 2025) vs ₹382.06 lakhs (Q2 2024) – 10% YoY growth

- Consolidated revenue: ₹43,849.60 lakhs (Q2 2025) vs ₹28,370.01 lakhs (Q2 2024) – 55% YoY growth

- Consolidated net profit: ₹266.58 lakhs (Q2 2025) vs ₹372.04 lakhs (Q2 2024) – 28% YoY decline

- Standalone total assets: ₹1,00,546.75 lakhs (Sep 2025) vs ₹1,01,686.65 lakhs (Mar 2025)

- Consolidated total assets: ₹1,01,417.53 lakhs (Sep 2025) vs ₹1,02,620.74 lakhs (Mar 2025)

- Primary business segment: Seed cultivation

- Financials available at www.nathbiogenes.com